title: Characterisation of the Trypanosoma brucei rhodesiense isolates from Tanzania using serum resistance associated gene as molecular marker.
abstract: Serum resistance associated (SRA) gene has been found to confer resistance to the innate trypanolytic factor (TLF) found in normal human serum; thus allowing Trypanosoma brucei brucei to survive exposure to normal human serum. This study was carried out to examine the presence of SRA gene and identify the origin of T. b. rhodesiense isolates from three districts in Tanzania, namely Kibondo, Kasulu and Urambo. Twenty-six T. b. rhodesiense isolates and two references T. b. rhodesiense isolates from Kenya were examined for SRA gene using simple Polymerase Chain Reaction technique. The gene was found to be present in all 26 T. b. rhodesiense isolates including the two references isolates from Kenya. The SRA gene was confirmed to be specific to T. b. rhodesiense since it could not be amplified from all other Trypanozoon including T. b. gambiense; and gave an amplified fragment of the expected size (3.9kb), confirming that all these isolates were T. b. rhodesiense of the northern variant. Although the geographic distributions of T. b. gambiense and T. b. rhodesiense are clearly localized to west/central Africa and eastern Africa, respectively, natural movement of people and recent influx of large number of refugees into Tanzania from the Democratic Republic of Congo, could have brought T. b. gambiense in western Tanzania. The overlap in distribution of both of these pathogenic sub-species could result in erroneous diagnoses since both trypanosome sub-species are morphologically identical, and currently serologic methods have low specificity. Both the susceptible and resistant T. b. rhodesiense isolates possessed the SRA gene suggesting that there is no correlation between drug resistance and presence of SRA gene. The use of SRA gene helps to confirm the identity and diversity of some of the isolates resistant to various drugs.
authors.affiliation: National Institute for Medical Research, P.O. Box 482, Tabora, Tanzania. kibonastbr@yahoo.com
authors.forename: S N
authors.initials: SN
authors.lastname: Kibona
authors.forename: K
authors.initials: K
authors.lastname: Picozzi
authors.forename: L
authors.initials: L
authors.lastname: Matemba
authors.forename: G W
authors.initials: GW
authors.lastname: Lubega
mesh_terms: D000818:Animals; D017931:DNA Primers; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005843:Geography; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics*; D016133:Polymerase Chain Reaction; D015800:Protozoan Proteins / Q000235:genetics*; D013636:Tanzania / Q000453:epidemiology; D016833:Trypanosoma brucei rhodesiense / Q000235:genetics* / Q000302:isolation & purification; D014353:Trypanosomiasis, African / Q000453:epidemiology / Q000235:genetics* / Q000469:parasitology
chemical_list: D017931:DNA Primers; D005819:Genetic Markers; D008562:Membrane Glycoproteins; D015800:Protozoan Proteins; C403774:serum resistance associated protein, Trypanosoma brucei